{
    "2020-06-18": [
        [
            {
                "time": "",
                "original_text": "每日医药简讯：石药集团注射用硼替佐米获得批准、宏力医疗通过港交所聆讯",
                "features": {
                    "keywords": [
                        "石药集团",
                        "注射用硼替佐米",
                        "获批",
                        "宏力医疗",
                        "港交所聆讯"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【国信医药】创新药品与器械密集获批，IVD检测需求持续（周观点）",
                "features": {
                    "keywords": [
                        "国信医药",
                        "创新药品",
                        "器械获批",
                        "IVD检测",
                        "需求持续"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}